The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation

British Journal of Pharmacology

Volumn 145, Issue 6, 2005, Pages 712-727

  Deschamps, Kathleen ^a   Couture, Réjean ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Behaviours; Cardiovascular regulation; Dopamine; NK 2 and NK 3 receptors; Tachykinin NK 1; Tachykinins; Ventral tegmental area

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; LANEPITANT; N (ALPHA ETHYLBENZYL) 3 (CARBOXYMETHOXY) 2 PHENYLQUINOLINE 4 CARBOXAMIDE; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; NEUROKININ A [4-10][8 BETA ALANINE]; RACLOPRIDE; SAREDUTANT; SB 235375; SENKTIDE; SUBSTANCE P DERIVATIVE; TACHYKININ; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR AGONIST; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BLOOD PRESSURE; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG ANTAGONISM; DRUG MECHANISM; DRUG TARGETING; HEART RATE; MALE; MESENCEPHALON; MICROINJECTION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; REARING; SCRATCHING; SNIFFING; STRESS; VENTRAL TEGMENTUM; WET DOG SHAKES;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ACETIC ACIDS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ATENOLOL; BEHAVIOR, ANIMAL; BENZAMIDES; BLOOD PRESSURE; GLUTAMIC ACID; HEART RATE; INDOLES; MALE; NEUROKININ A; PEPTIDE FRAGMENTS; PIPERIDINES; QUINOLINES; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RECEPTORS, NEUROKININ-3; SUBSTANCE P; VENTRAL TEGMENTAL AREA;

EID: 23044439472     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706249     Document Type: Article

References (70)

1. ADVENIER, C., ROUISSI, N., NGUYEN, Q.T., EMONDS-ALT, X., BRELIERE, J.C., NELIAT, G., NALINE, E. & REGOLI, D. (1992). Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist. Biochem. Biophys. Res. Commun., 184, 1418-1424.
2. AL MASKATI, H.A. & ZBROZYNA, A.W. (1989). Stimulation in prefrontal cortex area inhibits cardiovascular motor components of the defence reaction in rats. J. Auton. Nerv. Syst., 28, 117-125.
3. ALTIER, N. & STEWART, J. (1999). The tachykinin NK-1 receptor antagonist, RP-67580, infused into the ventral tegmental area prevents stress-induced analgesia in the formalin test. Physiol. Behav., 66, 717-721.
4. BANNON, M.J., DEUTCH, A.Y., TAM, S.Y., ZAMIR, N., ESKAY, R.L., LEE, J.M., MAGGIO, J.E. & ROTH, R.H. (1986). Mild footshock stress dissociates substance P from substance K and dynorphin from Met- and Leu-enkephalin. Brain Res., 381, 393-396.
5. CADOR, M., RIVET, J.M., KELLEY, A.E., LE MOAL, M. & STINUS, L. (1989). Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Brain Res., 486, 357-363.
6. 1 receptor antagonists in the rat. Br. J. Pharmacol., 127, 717-728.
7. 3 receptor antagonists in the conscious rat. Br. J. Pharmacol., 122, 643-654.
8. 3): a double immunocytochemical study in the rat. Brain Res., 780, 150-154.
9. CORNISH, J.L. & VAN DEN BUUSE, M. (1994). Pressor responses to electrical and chemical stimulation of the rat brain A10 dopaminergic system. Neurosci. Lett., 176, 142-146.
10. CORNISH, J.L. & VAN DEN BUUSE, M. (1995). Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin. Brain Res., 701, 28-38.
11. COUTURE, R., PICARD, P., POULAT, P. & PRAT, A. (1995). Characterization of the tachykinin receptors involved in spinal and supraspinal cardiovascular regulation. Can. J. Physiol. Pharmacol., 73, 892-902.
12. CUELLO, A.C., EMSON, P.C., PAXINOS, G. & JESSELL, T. (1978). Substance P containing and cholinergic projections from the habenula. Brain Res., 149, 413-429.
13. CULMAN, J. & UNGER, T. (1995). Central tachykinins: mediators of defence reaction and stress reactions. Can. J. Physiol. Pharmacol., 73, 885-891.
14. DEUTCH, A.Y., MAGGIO, J.E., BANNON, M.J., KALIVAS, P.W., TAM, S.Y., GOLDSTEIN, M. & ROTH, R.H. (1985). Substance K and substance P differentially modulate mesolimbic and mesocortical systems. Peptides, 6 (Suppl 2), 113-122.
15. 3) in the central nervous system of the rat. J. Comp. Neurol., 364, 290-310.
16. EISON, A.S., EISON, M.S. & IVERSEN, S.D. (1982). The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain. Brain Res., 238, 137-152.
17. ELLIOTT, P.J., ALPERT, J.E., BANNON, M.J. & IVERSEN, S.D. (1986a). Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area. Brain Res, 363, 145-147.
18. ELLIOTT, P.J. & IVERSEN, S.D. (1986). Behavioural effects of tachykinins and related peptides. Brain Res., 381, 68-76.
19. ELLIOTT, P.J., MASON, G.S., GRAHAM, E.A., TURPIN, M.P. & HAGAN, R.M. (1992). Modulation of the rat mesolimbic dopamine pathway by neurokinins. Behav. Brain. Res., 51, 77-82.
20. ELLIOTT, P.J., MASON, G.S., STEPHENS-SMITH, M. & HAGAN, R.M. (1991). Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists. Neuropeptides, 19, 119-126.
21. ELLIOTT, P.J., NEMEROFF, C.B. & KILTS, C.D. (1986b). Evidence for a tonic facilitatory influence of substance P on dopamine release in the nucleus accumbens. Brain Res., 385, 379-382.
22. 2) receptor. Life Sci., 50, PL101-PL106.
23. GERVAIS, J. & ROUILLARD, C. (2000). Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra. Synapse, 35, 281-291.
24. 2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics. Synapse, 30, 362-370.
25. GOODCHILD, A.K., DAMPNEY, R.A.L. & BANDLER, A. (1982). A method for evoking physiological responses by stimulation of cell bodies, but not axons of passage, within localized regions of the central nervous system. J. Neurosci. Methods, 6, 351-363.
26. HAY, D.W., GIARDINA, G.A., GRISWOLD, D.E., UNDERWOOD, D.C., KOTZER, C.J., BUSH, B., POTTS, W., SANDHU, P., LUNDBERG, D., FOLEY, J.J., SCHMIDT, D.B., MARTIN, L.D., KILIAN, D., LEGOS, J.J., BARONE, F.C., LUTTMANN, M.A., GRUGNI, M., RAVEGLIA, L.F. & SARAU, H.M. (2002). Non-peptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs. J. Pharmacol. Exp. Ther., 300, 314-323.
27. HYMAN, S.E. & MALENKA, R.C. (2001). Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci., 2, 695-703.
28. ITOI, K., JOST, N., BADOER, E., TSCHöPE, C., CULMAN, J. & UNGER, T. (1991). Localization of the substance P-induced cardiovascular responses in the rat hypothalamus. Brain Res., 558, 123-126.
29. ITOI, K., JOST, N., CULMAN, J., TSCHöPE, C. & UNGER, T. (1994). Further localization of cardiovascular and behavioral actions of substance P in the rat brain. Brain Res., 668, 100-106.
30. ITOI, K., TSCHöPE, C., JOST, N., CULMAN, J., LEBRUN, C., STAUSS, B. & UNGER, T. (1992). Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats. Eur. J. Pharmacol., 219, 435-444.
31. IYENGAR, S., HIPSKIND, P.A., GEHLERT, D.R., SCHOBER, D., LOBB, K.L., NIXON, J.A., HELTON, D.R., KALLMAN, M.J., BOUCHER, S., COUTURE, R., LI, D.L. & SIMMONS, R.M. (1997). LY303870, a centrally active neurokinin-1 antagonist with a long duration of action. J. Pharmacol. Exp. Ther., 280, 774-785.
32. KALIVAS, P.W., DEUTCH, A.Y., MAGGIO, J.E., MANTYH, P.W. & ROTH, R.H. (1985). Substance K and substance P in the ventral tegmental area. Neurosci. Lett., 57, 241-246.
33. KAWAHARA, Y., KAWAHARA, H. & WESTERINK, B.H. (2002). Hypotension-induced dopamine release in prefrontal cortex is mediated by local glutamatergic projections at the level of nerve terminals. J. Neurochem., 81, 285-291.
34. KELLEY, A.E., STINUS, L. & IVERSEN, S.D. (1979). Behavioural activation induced in the rat by substance P infusion into ventral tegmental area: implication of dopaminergic A10 neurones. Neurosci. Lett., 11, 335-339.
35. KIROUAC, G.J. & CIRIELLO, J. (1997a). Cardiovascular depressor responses to stimulation of substantia nigra and ventral tegmental area. Am. J. Physiol. (Heart Circ. Physiol.), 42, H2549-H2557.
36. KIROUAC, G.J. & CIRIELLO, J. (1997b). Cardiovascular afferent inputs to ventral tegmental area. Am. J. Physiol., 272, R1998-R2003.
37. KIROUAC, G.J. & GANGULY, P.K. (1993). Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis. Neuroscience, 52, 135-141.
38. LANGLOIS, X., WINTMOLDERS, C., TE RIELE, P., LEYSEN, J.E. & JURZAK, M. (2001). Detailed distribution of neurokinin-3 receptors in the rat, guinea pig and gerbil brain: a comparative autoradiographic study. Neuropharmacology, 40, 242-253.
39. LE MOAL, M. & SIMON, H. (1991). Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev., 71, 155-234.
40. LEJEUNE, F., GOBERT, A. & MILLAN, M.J. (2002). The selective neurokinin (NK-1) antagonist, GR205, 171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study. Brain Res., 935, 134-139.
41. LESSARD, A., CAMPOS, M.M., NEUGEBAUER, W. & COUTURE, R. (2003). Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study. Br. J. Pharmacol., 138, 554-563.
42. LESSARD, A. & COUTURE, R. (2001). Modulation of cardiac activity by tachykinins in the rat substantia nigra. Br. J. Pharmacol., 134, 1749-1759.
43. LU, X.Y., GHASEMZADEH, M.B. & KALIVAS, P.W. (1998). Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens. Neuroscience, 82, 767-780.
44. 3 receptor stimulation: an in vivo microdialysis approach in guinea pig. Neuropeptides, 32, 481-488.
45. 4 receptors: an in vitro and in vivo comparison with L 745, 870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H- pyrrolo[2, 3b]pyridine) and raclopride. J. Pharmacol. Exp. Ther., 287, 167-186.
46. NAKANISHI, S. (1991). Mammalian tachykinin receptors. Annu. Rev. Neurosci., 14, 123-136.
47. OADES, R.D. & HALLIDAY, G.M. (1987). Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res., 434, 117-165.
48. OVERTON, P., ELLIOTT, P.J., HAGAN, R.M. & CLARK, D. (1992). Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat. Eur. J. Pharmacol., 213, 165-166.
49. PAXINOS, G. & WATSON, C. (1998). The Rat Brain In Stereotaxic Coordinates. New York: Academic Press, S.B.
50. PICARD, P., REGOLI, D. & COUTURE, R. (1994). Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists. Br. J. Pharmacol., 112, 240-249.
51. REGOLI, D., DRAPEAU, G., DION, S. & COUTURE, R. (1988). New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization. Trends Pharmacol. Sci., 9, 290-295.
52. RIBEIRO-DA-SILVA, A., MCLEOD, A.L. & KRAUSE, J.E. (2000). Neurokinin receptors in the CNS. In: Handbook of Chemical Neuroanatomy, ed. Quirion, R., Björklund, A. & Hökfelt, T. Vol. 16, Part I. Peptide Receptors, pp. 195-240. Amsterdam: Elsevier Science B.V.
53. ROVERO, P., PESTELLINI, V., PATACCHINI, R., GIULIANI, S., SANTICIOLI, P., MAGGI, C.A., MELI, A. & GIACHETTI, A. (1989). A potent and selective agonist for NK-2 tachykinin receptor. Peptides, 10, 593-595.
54. 2 binding sites in the rat brain. J. Neurochem., 79, 985-996.
55. SAKATA, M., SEI, H., TOIDA, K., FUJIHARA, H., URUSHIHARA, R. & MORITA, Y. (2002). Mesolimbic dopaminergic system is involved in diurnal blood pressure regulation. Brain Res., 928, 194-201.
56. SEI, H., IKEMOTO, K., ARAI, R. & MORITA, Y. (1999). Injection of 6-hydroxydopamine into the ventral tegmental area suppresses the increase in arterial pressure during REM sleep in the rat. Sleep Res. Online, 2, 1-6.
57. SHUGHRUE, P.J., LANE, M.V. & MERCHENTHALER, I. (1996). In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system. J. Comp. Neurol., 372, 395-414.
58. STOESSL, A.J., DOURISH, C.T. & IVERSEN, S.D. (1990). Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT. Brain Res., 517, 111-116.
59. SWANSON, L.W. (1982). The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull., 9, 321-353.
60. SWANSON, L.W. (2000). Cerebral hemisphere regulation of motivated behavior(1). Brain Res., 886, 113-164.
61. TAKANO, Y., NAGASHIMA, A., HAGIO, T., TATEISHI, K. & KAMIYA, H. (1990). Role of central tachykinin peptides in cardiovascular regulation in rats. Brain Res., 528, 231-237.
62. TAMIYA, R., HANADA, M., KAWAI, Y., INAGAKI, S. & TAKAGI, H. (1990). Substance P afferents have synaptic contacts with dopaminergic neurons in the ventral tegmental area of the rat. Neurosci. Lett., 110, 11-15.
63. 2 receptors in the rat. Br. J. Pharmacol., 107, 750-755.
64. UNGER, T., CAROLUS, S., DEMMERT, G., GANTEN, D., LANG, R.E., MASER-GLUTH, C., STEINBERG, H. & VEELKEN, R. (1988). Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization. Circ. Res., 63, 812-820.
65. VAN DEN BUUSE, M. (1997). Pressor responses to brain dopaminergic stimulation. Clin. Exp. Pharmacol. Physiol., 24, 764-769.
66. VAN DEN BUUSE, M. (1998). Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats. Clin. Exp. Pharmacol. Physiol., 25, 661-668.
67. VAN DEN BUUSE, M. & CATANZARITI, R. (2000). Stimulation of the ventral tegmental area enhances the effect of vasopressin on blood pressure in conscious rats. Br. J. Pharmacol., 129, 29-36.
68. VAUGHAN, C.E., VAN DEN BUUSE, M. & ROLAND, B.L. (1999). Brain dopamine D2 receptor mRNA levels are elevated in young spontaneously hypertensive rats. Neurosci. Res., 34, 199-205.
69. WARDEN, M.K. & YOUNG III, W.S. (1988). Distribution of cells containing mRNAs encoding substance P and neurokinin B in the rat central nervous system. J. Comp. Neurol., 272, 90-113.
70. WORMSER, U., LAUFER, R., HART, Y., CHOREV, M., GILON, C. & SELINGER, Z. (1986). Highly selective agonists for substance P receptor subtypes. EMBO J., 5, 2805-2808.